Pancreatic Adenocarcinoma Therapeutics Market Size Analysis To 2019
Pancreatic adenocarcinoma is also referred to as pancreatic cancer (PC). It is an illness primarily affecting the elderly populace. Seventy five percent of pancreatic adenocarcinomas are detected in patients aged more than seventy five years. Pancreatic cancer grows fast, is asymptomatic initially, and displays only non-specific symptoms later.
Pancreatic adenocarcinoma is also referred to as pancreatic cancer (PC). It is an illness primarily affecting the elderly populace. Seventy five percent of pancreatic adenocarcinomas are detected in patients aged more than seventy five years. Pancreatic cancer grows fast, is asymptomatic initially, and displays only non-specific symptoms later.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
6.1.4 Novogen Enters Into Licensing Agreement with Marshall Edwards For NV-196 And NV-<br />
143 90<br />
6.2 Co-Development Deals 90<br />
6.2.1 Merck Serono Enters Into Co-Development Agreement with Threshold Pharma for TH-302<br />
92<br />
7 Appendix 93<br />
7.1 All Pipeline Drugs by Phase 93<br />
7.1.1 Discovery 93<br />
7.1.2 Preclinical 95<br />
7.1.3 IND/CTA-Filed 103<br />
7.1.4 Phase I 103<br />
7.1.5 Phase II 105<br />
7.1.6 Phase III 110<br />
Access Full Report: http://www.radiantinsights.com/research/pancreatic-adenocarcinomatherapeutics-in-major-developed-markets-to-<strong>2019</strong>-early-stage-pipeline-shows-diversity-ofnovel-targets-though-commercial-impact-remains-distant<br />
7.1.7 Pre-Registration 111<br />
7.2 <strong>Market</strong> Forecasts to <strong>2019</strong> 111<br />
7.2.1 Global 111<br />
7.2.2 US 112<br />
7.2.3 Canada 112<br />
7.2.4 UK 113<br />
7.2.5 France 113<br />
7.2.6 Germany 114<br />
7.2.7 Italy 114<br />
7.2.8 Spain 115<br />
7.2.9 Japan 115<br />
7.3 Abbreviations 116<br />
7.4 References 117<br />
7.5 Methodology 122<br />
7.6 Secondary Research 122<br />
7.7 Contact Us 122<br />
7.8 Disclaimer 122<br />
List Of Figure:<br />
Table 1: <strong>Pancreatic</strong> Cancer <strong>Therapeutics</strong>, Inherited Cancer Syndromes Associated with an<br />
Increased Risk of <strong>Pancreatic</strong> Cancer 11<br />
Table 2: <strong>Pancreatic</strong> Cancer <strong>Therapeutics</strong>, Common Mutations in <strong>Pancreatic</strong> Cancer 12<br />
Table 3: <strong>Pancreatic</strong> Cancer <strong>Therapeutics</strong>, Tumor Staging in <strong>Pancreatic</strong> Cancer 14<br />
Table 4: <strong>Pancreatic</strong> Cancer <strong>Therapeutics</strong>, ECOG Performance Status Scores and Description 15
Change language